TVTX
$49.60-6.04%
Travere Therapeutics Inc.Stock · HealthcareRussell 2000 0.2%Nasdaq Composite 0.01%US Stock Market 0.007%Russell 3000 0.006%
Travere Therapeutics Inc. total returns by year (including dividends)
As of market close, Oct 16, 2026
Travere Therapeutics Inc. total returns by year (2013–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $38.21 | $49.60 | 0.0% | +29.8% | |
| 2025 | $17.42 | $38.21 | 0.0% | +119.3% | |
| 2024 | $8.99 | $17.42 | 0.0% | +93.8% | |
| 2023 | $21.03 | $8.99 | 0.0% | -57.3% | |
| 2022 | $31.04 | $21.03 | 0.0% | -32.2% | |
| 2021 | $27.26 | $31.04 | 0.0% | +13.9% | |
| 2020 | $14.20 | $27.26 | 0.0% | +91.9% | |
| 2019 | $22.63 | $14.20 | 0.0% | -37.3% | |
| 2018 | $21.07 | $22.63 | 0.0% | +7.4% | |
| 2017 | $18.93 | $21.07 | 0.0% | +11.3% | |
| 2016 | $19.29 | $18.93 | 0.0% | -1.9% | |
| 2015 | $12.24 | $19.29 | 0.0% | +57.6% | |
| 2014 | $7.00 | $12.24 | 0.0% | +74.9% | |
| 2013 | $3.35 | $7.00 | 0.0% | +109.0% |
- Annualized
- +26.0%
- 2013–2026
- Average year
- +34.6%
- 13 full years
- Best year
- +119.3%
- 2025
- Worst year
- -57.3%
- 2023
- Positive years
- 9/13
- 69% up
Annualized (CAGR)
+26.0%
2013–2026
Average year
+34.6%
13 full years
Best year
+119.3%
2025
Worst year
-57.3%
2023
Positive years
9/13
69% up
Total return by period#
Annual
-100%-50%0%50%100%
2013+109%'13
2014+75%'14
2015+58%'15
2016-1.9%'16
2017+11%'17
2018+7.4%'18
2019-37%'19
2020+92%'20
2021+14%'21
2022-32%'22
2023-57%'23
2024+94%'24
2025+119%'25
2026+30%'26
Methodology#
Total returns, dividends reinvested, measured on TVTX. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Travere Therapeutics Inc.'s average annual return?
- Since 2013, Travere Therapeutics Inc. (TVTX) has returned about 26.0% a year (the compound annual growth rate) and an average calendar-year return of 34.6%.
- What were Travere Therapeutics Inc.'s best and worst years?
- Over 2013–2026, the best year was 2025 (+119.3%) and the worst was 2023 (-57.3%).
- How often is Travere Therapeutics Inc. up in a year?
- 9 of the 13 full years since 2013 were positive — about 69% of the time.
More on Travere Therapeutics Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100